Copenhagen, Denmark

Thomas Boesen

This inventor holds 14 USPTO granted patents and 8 published patent applications, plus 5 CIPO patents and 7 EPO patents. Top assignees: Txp Pharma Gmbh, Gilead Sciences, Inc., Lica Pharmaceuticals A/s. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Boesen. Retrieved from https://idiyas.com/inventor/thomas-boesen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 85.7

 

 

Average Co-Inventor Count = 2.2

ph-index = 3

Forward Citations = 17(Granted Patents)


Location History:

  • København Ø, DK (2015 - 2017)
  • Københan Ø, DK (2017)
  • Københaven Ø, DK (2019)
  • Copenhagen, DK (2008 - 2021)

Company Filing History:


Years Active: 2008-2026

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Thomas Boesen

Introduction

Thomas Boesen is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of pharmaceuticals, holding a total of 13 patents. His work focuses on developing innovative solutions that enhance the efficacy and solubility of medicinal compounds.

Latest Patents

Among his latest patents is the invention titled "Polymorphs of phenyl pyrrole aminoguandium salts." This patent relates to crystalline forms of N-{3-[1-(2-nitrophenyl)-1H-pyrrol-2-yl]-allylidene}-aminoguanidinium salts, which exhibit high solubility. The disclosure emphasizes the potential use of these crystalline forms in medicine. Another significant patent is "Peptide analogues with branched amino acid probe(s)," which involves peptide analogues that comprise one or more branched amino acid probes along with a peptide, either in its native form or as variants.

Career Highlights

Throughout his career, Thomas Boesen has worked with prominent companies in the pharmaceutical industry, including Txp Pharma GmbH and Gilead Sciences, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field.

Collaborations

Thomas has collaborated with several professionals in his field, including Marc A. Labelle and Farman Ullah. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Thomas Boesen's innovative contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new medicinal compounds that can improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…